Headline
The latest stories from AHA Today.
States may apply until Jan. 20 for grants to implement and enforce certain market reforms and consumer protections to strengthen the private health insurance market under the Affordable Care Act, the Centers for Medicare & Medicaid Services announced.
The House of Representatives passed by voice vote the Bipartisan Solution to Cyclical Violence Act (H.R. 5855), AHA-supported legislation that would create a $10 million Department of Health and Human Services grant program to fund violence prevention programs linked to trauma centers and examine…
Join AHA and the Centers for Disease Control and Prevention Friday at 2 p.m. ET for a Project Firstline conversation on caring safely for COVID-19 patients.
Sarah Krevans, president and CEO of Sutter Health, will join AHA Board Chair Melinda Estes, M.D., Nov. 19 at 3:30 p.m. ET to discuss how hospitals can move from relief, recovery, and rebuilding to reimagining and innovation.
The Food and Drug Administration issued an emergency use authorization for the Lucira COVID-19 All-In-One Test Kit, the first rapid test to detect the COVID-19 virus that one can administer completely at home when prescribed by a health care provider to individuals age 14 or older.
The Department of Health and Human Services issued clarifications sought by the AHA on two problematic reporting requirements for the Provider Relief Fund.
The Centers for Medicare & Medicaid Services on Dec. 1 will retire Hospital Compare and seven other health care quality compare websites, whose content has been transitioning since September to a single website called Care Compare.
The National Institutes of Health will fund six research projects to examine disparities in pregnancy-related complications and deaths among disproportionately affected women, including racial and ethnic minority groups, underprivileged women and those in underserved rural settings.
The Food and Drug Administration issued final guidance for health care providers and researchers using investigational COVID-19 convalescent plasma, defined as convalescent plasma that does not meet all conditions of the agency’s emergency use authorization or which is used under an investigational…
The Department of Health and Human Services has released a PPE Preservation Planning Toolkit to help organizations implement strategies to preserve personal protective equipment during the COVID-19 pandemic.